(Q53096322)

English

De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24456026

De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24456026

phase II clinical trial

0 references

liver transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Sumeet K Asrani

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

John Julian Fung

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

R H Wiesner

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

J F Trotter

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

G Klintmalm

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

E Katz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

E Maller

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

J Roberts

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

N Kneteman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

L Teperman

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

J M Millis

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

0 references

publication date

23 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24456026

American Journal of Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

356-366

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456026%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Chronic renal dysfunction late after liver transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Chronic renal failure after transplantation of a nonrenal organ

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Sirolimus and cardiovascular disease risk in liver transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Sirolimus--it doesn't deserve its bad Rap(a).

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Rapamycin: friend, foe, or misunderstood?

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Biliary complications after orthotopic liver transplantation: a review of incidence and risk factors

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

A Decade of Experience Using mTor Inhibitors in Liver Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Effects of everolimus monotherapy on hematological parameters and iron homeostasis in de novo liver transplant recipients: preliminary results

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Everolimus with reduced tacrolimus in liver transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12543

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53096322&oldid=2064123048"